Online citations, reference lists, and bibliographies.
← Back to Search

Labeling Of Immune Cells For In Vivo Imaging Using Magnetofluorescent Nanoparticles

M. Pittet, F. Swirski, Frederick D Reynolds, L. Josephson, R. Weissleder
Published 2006 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Observation of immune and stem cells in their native microenvironments requires the development of imaging agents to allow their in vivo tracking. We describe here the synthesis of magnetofluorescent nanoparticles for cell labeling in vitro and for multimodality imaging of administered cells in vivo. MION-47, a prototype monocrystalline iron oxide nanoparticle, was first converted to an intermediate bearing a fluorochrome and amine groups, then reacted with either HIV-Tat peptide or protamine to yield a nanoparticle with membrane-translocating properties. We describe how to assess optimal cell labeling with tests of cell phenotype and function. Synthesis of magnetofluorescent nanoparticles and cell-labeling optimization can be realized in 48 h, whereas nanoparticle uptakes and retention studies may generally take up to 120 h. Labeled cells can be detected by magnetic resonance imaging, fluorescence reflectance imaging, fluorescence-mediated tomography, confocal microscopy and flow cytometry, and can be purified based on their fluorescent or magnetic properties. The present protocol focuses on T-cell labeling but can be used for labeling a variety of circulating cells.
This paper references
Transfection agent induced nanoparticle cell
K. Montet-Abou (2005)
10.1038/nbt805
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
G. Koehne (2003)
10.1161/01.CIR.0000149840.46523.FC
In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease
J. V. Frangioni (2004)
10.4049/jimmunol.166.12.7634
Ex Vivo IFN-γ Secretion by Circulating CD8 T Lymphocytes: Implications of a Novel Approach for T Cell Monitoring in Infectious and Malignant Diseases1
M. Pittet (2001)
10.1038/nature03043
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Catherine M. Shachaf (2004)
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
M. Kircher (2003)
10.1038/nm0103-123
Shedding light onto live molecular targets
R. Weissleder (2003)
10.1073/PNAS.0508698102
Visualization of a primary anti-tumor immune response by positron emission tomography.
C. Shu (2005)
10.4049/jimmunol.176.4.2330
Ex Vivo Characterization of Allo-MHC-Restricted T Cells Specific for a Single MHC-Peptide Complex1
M. Pittet (2006)
10.1038/nbt1159
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
R. Weissleder (2005)
10.1162/15353500200505100
Transfection Agent Induced Nanoparticle Cell Loading
Karin Montet-Abou (2005)
10.1038/nrc701
Scaling down imaging: molecular mapping of cancer in mice
R. Weissleder (2002)
10.1073/PNAS.91.2.664
Tat-mediated delivery of heterologous proteins into cells.
S. Fawell (1994)
10.1038/74464
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
10.1126/SCIENCE.285.5433.1569
In vivo protein transduction: delivery of a biologically active protein into the mouse.
S. Schwarze (1999)
implications of a novel approach for T cell monitoring in infectious and malignant diseases
Pittet (2001)
10.1038/nbt1074
Looking and listening to light: the evolution of whole-body photonic imaging
V. Ntziachristos (2005)
10.1038/nature02238
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
T. Mempel (2004)
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.
M. Pittet (2001)
10.1126/science.1121411
Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy
S. Thorne (2006)
TAT-p27Kip1 induces cell migration
Nagahara (1998)
10.4049/jimmunol.176.5.2902
Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control1
F. Vianello (2006)
10.1021/BC0501451
Protamine as an efficient membrane-translocating peptide.
F. Reynolds (2005)
10.1038/nbt1154
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
I. J. Vries (2005)
10.1084/jem.20030593
Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
T. Murakami (2003)
10.1038/nrc1167
Adoptive-cell-transfer therapy for the treatment of patients with cancer
M. Dudley (2003)
10.1038/4042
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration
H. Nagahara (1998)
10.1182/BLOOD-2004-02-0655
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.
A. Arbab (2004)
10.1126/SCIENCE.1076514
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
M. Dudley (2002)
10.1016/S0952-7915(00)00196-5
In vivo tracking of tumor-specific T cells.
C. Yee (2001)
10.1073/PNAS.0408197102
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
M. Chen (2005)



This paper is referenced by
10.1101/cshperspect.a003848
In vivo imaging in cancer.
J. Condeelis (2010)
10.1021/ja100254m
Modulation of T2 relaxation time by light-induced, reversible aggregation of magnetic nanoparticles.
E. Osborne (2010)
10.1016/j.msec.2013.05.009
Recyclable and stable silver deposited magnetic nanoparticles with poly (vinyl pyrrolidone)-catechol coated iron oxide for antimicrobial activity.
Tamim Mosaiab (2013)
10.1007/978-3-319-16555-4_3
Theranostic Magnetic Nanostructures (MNS) for Cancer.
V. Nandwana (2015)
10.1039/b916297f
Intracellular transduction using cell-penetrating peptides.
R. Sawant (2010)
10.1021/nn202912b
Synthesis and high performance of magnetofluorescent polyelectrolyte nanocomposites as MR/near-infrared multimodal cellular imaging nanoprobes.
H. Kim (2011)
10.1007/978-3-642-31107-9_19
Stabilization and Characterization of Iron Oxide Superparamagnetic Core-Shell Nanoparticles for Biomedical Applications
E. Reimhult (2014)
10.1002/wnan.4
Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.
R. Juliano (2009)
10.3727/096368912X657963
Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors
K. Butler (2013)
10.1039/B902170A
A screening paradigm for the design of improved polymer-coated superparamagnetic iron oxide nanoparticles
Shu Han Chen (2009)
10.1002/PPSC.201400152
Uptake and Intracellular Fate of Peptide Surface‐Functionalized Silica Hybrid Magnetic Nanoparticles In Vitro
R. Digigow (2015)
10.1038/ncomms14254
Covalent assembly of nanoparticles as a peptidase-degradable platform for molecular MRI
F. Pérez-Balderas (2017)
10.1002/smll.201201007
Dual imaging and photoactivated nanoprobe for controlled cell tracking.
Sarit S Agasti (2013)
IRM cellulaire de lymphocytes marqués par des nanoparticules d'oxydes de fer : application au diagnostic en cancérologie
P. Mowat (2007)
10.1038/nature06917
Imaging in the era of molecular oncology
R. Weissleder (2008)
10.1039/c2cc17937g
Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents.
S. Cavalli (2012)
10.1039/c4cs00201f
Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging.
E. Debroye (2014)
10.2147/IJN.S158071
Optimization of molecularly targeted MRI in the brain: empirical comparison of sequences and particles
N. Zarghami (2018)
10.1016/J.JLUMIN.2013.03.035
In situ synthesis of Eu(Tp)3 complex inside the pores of mesoporous silica nanoparticles
Chandrashekhar Malba (2013)
10.1007/978-0-387-78608-7_5
Biomedical Applications of Nanoparticles
G. L. Prasad (2009)
10.1016/j.nano.2015.02.006
Toxicology of wear particles of cobalt-chromium alloy metal-on-metal hip implants Part II: Importance of physicochemical properties and dose in animal and in vitro studies as a basis for risk assessment.
A. Madl (2015)
In vivo and ex vivo applications of gold nanoparticles for biomedical SERS imagingi.
M. V. Yigit (2012)
10.1007/978-1-4939-3148-4
RNA Imaging
Z. Medarova (2016)
10.1016/j.coph.2014.08.002
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications.
Rongrong Jin (2014)
10.1016/j.addr.2011.07.001
Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications.
M. De (2011)
Identification of gold nanoparticle in lymphocytes: a confirmation of direct intracellular penetration effect.
V. Wiwanitkit (2009)
10.1038/nprot.2014.126
In situ simultaneous monitoring of ATP and GTP using a graphene oxide nanosheet–based sensing platform in living cells
Y. Wang (2014)
10.1042/BST0350816
Tatp-mediated intracellular delivery of pharmaceutical nanocarriers.
V. Torchilin (2007)
10.1002/9781118742952.CH46
Metal‐Based Chelates and Nanosystems as MRI Contrast Agents
S. Figueiredo (2013)
10.1021/BC070100V
Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles.
B. Steitz (2007)
10.1093/hmg/ddx378
Thrombospondin-1 and disease progression in dysferlinopathy
N. Urao (2017)
10.4172/2155-9929.1000102
Binding and Internalization of Iron Oxide Nanoparticles Targeted to Nuclear Oncoprotein.
L. Knight (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar